Study evaluates use of drought-tolerant maize in Africa

NewsGuard 100/100 Score

Reuters reports on a study (.pdf) examining the use of drought-tolerant maize in 13 African countries, which was published on Thursday by the International Maize and Wheat Improvement Centre (CIMMYT) with input from several other food research institutes (Cocks, 8/26).

The study found that drought-tolerant maize "can bring sub-Saharan Africa's farmers cumulative economic benefits of nearly USD 0.9 billion during 2007-16," according to CIMMYT press release. "This is assuming likely rates of adoption of drought-tolerant varieties," said the study's lead author Roberto La Rovere, an impacts specialist at CIMMYT. The drought-tolerant varieties "provide a yield advantage of 10% to 34% over normal improved varieties, depending on the site and seasonal conditions," La Rovere said.

The drought-tolerant maize was also found to provide higher and more stable yields, according to Wilfred Mwangi, associate director of CIMMYT's global maize program and a co-author of the study. "Small-scale agriculture in Africa is predominantly rainfed; few farmers have access to irrigation. Drought tolerant maize varieties are more dependable under varying rainfall conditions. This means that farmers will suffer less pronounced fluctuations in season-to-season yields, reducing their risk," Mwangi said.

Based on their calculations, La Rovere said the use of drought-tolerant maize has the potential to "help more than 4 million people to escape poverty and many millions more to improve their livelihoods." The most significant economic benefits would occur in Nigeria, Kenya, and Malawi, La Rovere said. "This is a function of the amounts of maize sown in those countries, the importance of maize in local diets and livelihoods, and historical levels of adoption of improved maize there," he said.

The study was conducted in Angola, Benin, Ethiopia, Ghana, Kenya, Malawi, Mali, Mozambique, Nigeria, Tanzania, Uganda, Zambia and Zimbabwe (undated release).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials